Karmanos Cancer Institute

Stored: Karmanos Cancer Institute

Karmanos Cancer Institute Type: Non-profit Parent organization: McLaren Health Care Top organization: Employees: 1200 Executive: President and Chief Executive Officer Budget: $260,000,000 (FY 2018) Address: 4100 John R St, Detroit, MI 48201, USA Website: https://www.karmanos.org Creation Legislation: Wikipedia: Karmanos Cancer Institute

Karmanos Cancer Institute [{"name":"Karmanos Cancer Institute","title":"\u003Ca class=\"mw-selflink selflink\"\u003EKarmanos Cancer Institute\u003C\/a\u003E","lat":42.351829,"lon":-83.056094,"otherValues":{"HeadquartersAddress":"4100 John R St, Detroit, MI 48201, USA"}}] This map created from a Cargo query ()

Mission The Karmanos Cancer Institute leads in transformative cancer care, research, and education to improve patient outcomes through innovative treatments and scientific discovery. It strives to create a world free of cancer through courage, commitment, and compassion.

Services Cancer treatment; clinical trials; research programs; patient support services

Regulations

Karmanos Cancer Institute (KCI) is a leading non-profit cancer research and treatment network headquartered in Detroit, Michigan, established in 1943 as the Detroit Institute for Cancer Research. Designated as one of 57 National Cancer Institute (NCI) Comprehensive Cancer Centers, KCI operates 16 locations across Michigan and Ohio, treating approximately 12,000 new patients annually with cutting-edge therapies and over 800 clinical trials, bolstered by its academic partnership with Wayne State University School of Medicine.

Official Site

Mission

The Karmanos Cancer Institute is dedicated to delivering exceptional cancer care, advancing research, and educating the next generation of oncology professionals, with a vision of a cancer-free world. It integrates courage, commitment, and compassion into its efforts, offering more than 250 innovative treatments and fostering collaboration to enhance survivorship and prevention.

Parent organization

The Karmanos Cancer Institute is a subsidiary of McLaren Health Care, a Michigan-based healthcare system that acquired KCI in January 2014 to form the state’s largest cancer care and research network. This partnership enhances KCI’s ability to deliver comprehensive services across its 16 locations.

Legislation

KCI was not directly created by legislation but evolved from the Detroit Institute for Cancer Research, founded in 1943, and was formalized as a non-profit in 1949 under Michigan law. Its NCI designation as a Comprehensive Cancer Center, originally granted in 1978 to the Meyer L. Prentis Comprehensive Cancer Center, reflects federal recognition under the National Cancer Act of 1971.

Partners

KCI collaborates with:

• Wayne State University School of Medicine for research and education
• Detroit Medical Center for clinical programs
• Department of Energy and other federal entities for initiatives like CRISP
• Over 230 institutional partners across its network

Number of employees

KCI employs approximately 1,200 staff members, including nearly 300 faculty and 100 researchers, supporting its extensive clinical and research operations.

Organization structure

KCI is structured to integrate research, care, and education:

• Clinical Operations Team oversees 16 treatment sites.
• Research Division manages four NCI programs: Tumor Biology, Molecular Imaging, Molecular Therapeutics, and Population Studies.
• Education Team supports training through Wayne State University.

Leader

The Karmanos Cancer Institute is headed by a President and Chief Executive Officer.

Divisions

The divisions include:

• Clinical Services for oncology care across multiple specialties.
• Research Programs for advancing cancer science.
• Community Outreach for prevention and education initiatives.

List of programs

KCI oversees:

• Clinical Trials Program - https://www.karmanos.org/karmanos/clinical-trials
• Bone Marrow and Stem Cell Transplant Program
• Cancer Prevention and Screening Initiatives
• Genetic Counseling Services

Last total enacted budget

KCI’s last reported operating budget was $260,000,000 for FY 2018, encompassing patient care, research, and administration across its network.

Staff

KCI’s 1,200 staff include 300 physicians, 100 researchers, and numerous nurses and support personnel, forming a robust team dedicated to treating 12,000 new patients annually and conducting extensive research.

Funding

KCI is funded through McLaren Health Care, patient revenue, over $58 million in annual extramural research grants (including $36 million from NCI), and donor contributions from thousands of supporters, a model sustained since its 1949 non-profit status.

Services provided

KCI offers comprehensive cancer care including medical, radiation, and surgical oncology, over 800 clinical trials, patient support services like genetic counseling, and community outreach for early detection and prevention.

Regulations overseen

As a non-regulatory entity, KCI does not oversee federal regulations but adheres to NCI standards and healthcare regulations as an NCI-designated center.

Headquarters address

The headquarters address, as listed on Google Maps, is 4100 John R St, Detroit, MI 48201, USA.

History

Founded in 1943 as the Detroit Institute for Cancer Research, KCI became a non-profit in 1949 and gained NCI Comprehensive Cancer Center status in 1978 as the Meyer L. Prentis Comprehensive Cancer Center. Renamed in 1995 after Barbara Ann Karmanos following a merger with Wayne State University and Detroit Medical Center programs, it joined McLaren Health Care in 2014, expanding to 16 sites and solidifying its role as Michigan’s largest cancer network.

External links

• Official Website
• wikipedia:Karmanos_Cancer_Institute
• NCI Profile